Treatments & Interventions
Thyroglobulin
substance
Triiodothyronine
substance
Thyroxine
substance
Doxorubicin hydrochloride
substance
Levothyroxine sodium
substance
Liothyronine sodium
substance
Doxorubicin
substance
Interferon alfa-2b
substance
Daunorubicin hydrochloride liposome
substance
Thyrotropin alfa
substance
Vandetanib
substance
Sorafenib
substance
Sorafenib tosylate
substance
Levothyroxine
substance
Lenvatinib
substance
Lenvatinib mesylate
substance
Doxorubicin hydrochloride pegylated liposome
substance
Levothyroxine sodium anhydrous
substance
Selpercatinib
substance
Research Evidence
Peer-reviewed studies linked via MeSH term "Thyroid Neoplasms" from the MEDLINE/PubMed database.
Research data from MEDLINE/PubMed
Related Conditions
Quick Facts
- SNOMED CT
- 127018007
- UMLS CUI
- C0040136
- Fully Specified Name
- Neoplasm of thyroid gland (disorder)
- Specialists
- 0
- Diagnostic Biomarkers
- 0
- Known Treatments
- 19
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.